Who Owns Immunitybio Inc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Immunitybio Inc.
Who crossed 5% of IBRX →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| MFG WEALTH MANAGEMENT, INC.COM175.5K shadded | $1.7M |
| COLLECTIVE FAMILY OFFICE LLCCOM161.3K shadded | $1.5M |
| CenterStar Asset Management, LLCCOM38.7K shtrimmed | $365.3K |
| Private Capital Advisors, Inc.COM26.9K shtrimmed | $253.5K |
| Farther Finance Advisors, LLCStock16.5K shadded | $155.6K |
| Financial Enhancement Group LLCCOM10K shheld | $97.5K |
| GAMMA Investing LLCCommon Stock3.8K shadded | $35.9K |
| GK Wealth Management LLCCOM1.5K sh— | $14.5K |
| ELEVATION WEALTH PARTNERS, LLCCOM1.5K shheld | $14.2K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock246 shtrimmed | $2.3K |
| TOTH FINANCIAL ADVISORY CORPCOM140 shheld | $1.3K |
| Grove Bank & TrustCOM100 sh— | $944 |
| CoreCap Advisors, LLCStock23 shheld | $217 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on IBRX
Follow Immunitybio Inc (IBRX) by email
New trades in Immunitybio Inc (IBRX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.